Skip to main navigation Skip to search Skip to main content

Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations

  • Dongho Kim
  • , Dong Wook Kim
  • , Byung Sik Cho
  • , Hyun Gyung Goh
  • , Soo Hyun Kim
  • , Wan Seok Kim
  • , Jeong Lee
  • , Il Young Kweon
  • , Sa Hee Park
  • , Jeong Hyeok Yoon
  • , Nam Doo Kim
  • , Haarin Chun
  • Catholic University of Korea
  • Catholic Univ. of Korea Coll. Med.
  • Equispharm Ltd.

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology